secwatch.observer — SEC 8-K summary
======================================

Issuer:     COOPER COMPANIES, INC. (COO)
CIK:        0000711404
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0000711404-22-000046
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CooperCompanies Q4 revenue up 12% to $848M, but GAAP EPS falls 40%; FY2023 guidance issued
--------------------------------------------------------------------------------

- Q4 GAAP diluted EPS of $1.32 (down 40% YoY); non-GAAP diluted EPS of $2.75 (down 16%).
- Full-year FY2022 revenue $3,308.4M (+13% YoY); GAAP EPS $7.76 (down 87%), non-GAAP EPS $12.42 (down 6%).
- Q4 CooperVision revenue $561.8M (down 1% reported but +10% constant currency); CooperSurgical revenue $286.3M (+47% reported).
- FY2023 guidance: revenue $3,455-$3,515M (6-8% organic growth); non-GAAP EPS $12.30-$12.60.
- Pending Cook Medical Reproductive Health acquisition ($875M) not included in FY2023 guidance; awaits regulatory approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/711404/000071140422000046/0000711404-22-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/711404/000071140422000046/coo-20221208.htm
  HTML page:      https://secwatch.observer/filing/0000711404-22-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer